Executive-Led Medical Trade Mission to India Mumbai, New Delhi and Hyderabad March 2-8, 2012, 70113-70116 [2011-28590]

Download as PDF jlentini on DSK4TPTVN1PROD with NOTICES Federal Register / Vol. 76, No. 218 / Thursday, November 10, 2011 / Notices evidence in its ministerial error allegation that it was the Department’s intention in preparing the final results to use either the labor rate methodology announced on June 21, 2011, or to value lime using any surrogate value other than the one it used in the final results. Thus, XITIC’s allegations do not fall under the definition of a ministerial error set forth in 751(h) of the Act and 19 CFR 351.224(f). Therefore, the Department has not amended the final results with respect to XITIC’s allegations. Finally, Iceman Group argues that the Department made a clerical error by including Iceman Group in the proceedings. Iceman Group claims that no party requested a review of Iceman Group, and that the Department did not initiate an administrative review of shipments by Iceman Group. Instead, Iceman Group argues, petitioners requested a review of Zhejiang Iceman Food, Co., Ltd. (‘‘Iceman Food’’), and it was on this entity that the Department initiated an administrative review. Petitioner argues the Department should reject Iceman Group’s argument for three reasons: (1) Iceman Group actively participated in the administrative proceedings before the Department (submitting a separate rate certification) and its counsel filed an entry of appearance on behalf of Iceman Food; (2) the Department’s Preliminary Results 2 specifically identified Iceman Group as an entity preliminarily eligible for a separate rate; and (3) Iceman Group’s attempt to raise this issue as a clerical error—rather than having raised it during the Department’s on-going proceedings—is an inappropriate use of the clerical error provision in the Department’s regulations. After analyzing the interested parties’ allegations and reply comments regarding Iceman Group, in accordance with section 751(h) of the Act and 19 CFR 351.224(e), we find that the Department did not err by including Iceman Group in the proceedings. First, the allegations made by Iceman Group do not fall under the definition of ‘‘ministerial error’’ set forth in 751(h) of the Act and 19 CFR 351.224(f). Additionally, four reasons support equating Iceman Group with the entity Iceman Food: (1) Counsel filed an entry of appearance on behalf of Iceman Food on April 5, 2010; (2) Iceman Group, which never filed a separate notice of appearance, filed a certification for a separate rate on April 29, 2010; (3) the 2 See Certain Preserved Mushrooms From the People’s Republic of China: Preliminary Results of Antidumping Duty Administrative Review, Recission in Part, and Intent to Rescind in Part, 76 FR 12704 (March 8, 2011) (Preliminary Results) VerDate Mar<15>2010 16:38 Nov 09, 2011 Jkt 226001 separate rate certification filed by Iceman Group lists the company Web site as www.icemanfood.com and the company email address as ‘‘jacky@icemanfood.com;’’ and (4) Iceman Group did not comment on the Preliminary Results, which specifically list Iceman Group as preliminarily receiving a separate rate. Therefore, the Department correctly and reasonably assigned a separate rate to Iceman Group as a result of counsel’s representation of Iceman Group and Iceman Food, and the party’s own actions before the Department indicating that the two names apply to the same company which is subject to the review. Thus, the Department will not amend the Final Results for Iceman Group other than to account for adjustments to the weighted-average margin for companies that applied for separate-rates status as described above. Amended Final Results of the Review The Department has determined that the following amended margins exist for the period February 1, 2009, through January 31, 2010. Weightedaverage margin (percent) Exporter Blue Field (Sichuan) Food Industrial Co., Ltd .............. Ayecue (Liaocheng) Foodstuff Co., Ltd ..................... Fujian Golden Banyan Foodstuffs Industrial Co., Ltd .... Shandong Jiufa Edible Fungus Corporation, Ltd ......... Zheijiang Iceman Group Co., Ltd ..................................... 2.17 76.12 Fmt 4703 Sfmt 4703 Dated: November 4, 2011. Paul Piquado, Assistant Secretary for Import Administration. [FR Doc. 2011–29175 Filed 11–9–11; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE International Trade Administration Executive-Led Medical Trade Mission to India Mumbai, New Delhi and Hyderabad March 2–8, 2012 76.12 76.12 Mission Description Cash Deposit Requirements Cash deposit requirements related to the amended final results will be effective retroactively for all shipments of the subject merchandise entered, or withdrawn from warehouse, for consumption on or after the publication date of the final results, as provided by section 751(a)(2)(C) of the Act. The cash deposit rates for companies whose rate was corrected are noted above. For Frm 00007 previously investigated or reviewed PRC and non-PRC exporters that have separate rates whose rate has not changed as a result of these amended final results, the cash deposit rate will continue to be the exporter-specific rate published for the most recent period. For all PRC exporters of subject merchandise which have not been found to be entitled to a separate rate, the cash deposit rate will be the PRCwide rate of 198.63 percent. For all nonPRC exporters of subject merchandise which have not received their own rate, the cash deposit will be the rate applicable to the PRC exporters that supplied that non-PRC exporter. These deposit requirements shall remain in effect until further notice. These amended final results are published in accordance with sections 751(h) and 777(i)(1) of the Act. International Trade Administration, Commerce. ACTION: Notice. 76.12 Assessment Rates Pursuant to section 751(a)(2)(A) of the Act and 19 CFR 351.212(b), the Department shall determine, and U.S. Customs and Border Protection (CBP) shall assess, antidumping duties on all appropriate entries. The Department intends to issue assessment instructions to CBP that are related to the amended final results 15 days after the of publication of the amended final results of review. PO 00000 70113 AGENCY: The United States Department of Commerce, International Trade Administration, U.S. and Foreign Commercial Service (CS) is organizing an Executive-Led Medical Trade Mission to India from March 2–8, 2012. The Medical Trade Mission to India is intended to include representatives from a variety of U.S. medical/ healthcare industry manufacturers (equipment/devices, laboratory equipments, emergency equipment, diagnostic, physiotherapy and orthopedic, healthcare information technology, and other allied sectors), service providers, and associations and trade organizations. The mission will introduce the participants to the government bodies, end-users and prospective partners whose needs and capabilities are best suited to each U.S. participant’s strengths. Participating in an official U.S. industry delegation, rather than traveling to India on their own, will enhance the participants’ E:\FR\FM\10NON1.SGM 10NON1 70114 Federal Register / Vol. 76, No. 218 / Thursday, November 10, 2011 / Notices jlentini on DSK4TPTVN1PROD with NOTICES ability to secure meetings in India. The delegates will meet with government officials to obtain first-hand information about the regulations, policies and procedures in the healthcare industry. It will be an opportunity for participants to visit healthcare facilities to get acquainted with the functioning of hospitals in India and the varied standards. Market forces, such as medical tourism, insurance and corporate sector have accelerated the demand for quality in healthcare services. As a result, there is a growing demand from consumers for better healthcare as the lack of quality assurance mechanisms limits their access to appropriate health services. The Healthcare industry is now proactively creating standards for the medical tourism industry with the help of credit rating agencies, insurance companies and others involved in the self regulation of the sector. The National Accreditation Board for Hospitals (NABH) has been set-up to establish and operate accreditation programs for healthcare organizations. Some private hospitals are also applying for accreditation from bodies such as the Joint Commission International (JCI). The mission will include appointments and briefings in Mumbai, New Delhi and Hyderabad, India’s major healthcare industry hubs. Trade mission participants will have the opportunity to interact extensively with Embassy/ Consulate Officials and Commercial Service (CS) India healthcare specialists, to discuss industry developments, opportunities, and sales strategies. There is an option in the mission to participate in Medical Fair India. The Medical Fair India is the 18th International Exhibition and Conference on Diagnostic, Medical Technology, Rehabilitation, Medical Equipment and Components. MEDICAL FAIR INDIA offers a new platform for technology and service solutions for use in the medical engineering industry—from new materials, components, intermediate products, packaging and services all the way over to more complex micro system technology and nanotechnology. For more information on Medical Fair India, please visit https://www.medicalfairindia.com/. For the last three years the U.S. Department of Commerce has certified the Medical Fair India. Commercial Setting The Indian healthcare industry is experiencing a rapid transformation and emerging to be a promising market for U.S. suppliers of high end products seeking partnership opportunities. The Indian healthcare industry is estimated at $50 billion industry in India and is VerDate Mar<15>2010 16:38 Nov 09, 2011 Jkt 226001 expected to reach over $75 billion by 2012. There is a growing demand for quality healthcare service. The Indian population of 1 billion people is growing at a rate of 1.6 percent per year. The growth in affluence in India, which now has over 400 million middleincome consumers, is creating demand for a higher standard of healthcare. The type of healthcare serviced required have changed due to the change in the demographic profile of India and the rise of lifestyle-related diseases such as diabetes, cardiovascular diseases, and diseases of the central nervous system. The number of individuals covered by health plans is estimated at 20 million presently, leaving a large portion of the Indian population uninsured. The potential market for healthcare services, including healthcare information and management systems, is expected to grow at a faster pace as hospitals strive to improve operational efficiencies in managing patient records and other key systems. Currently, the medical infrastructure in India is far from adequate with demand for hospitals and beds far surpassing availability. The problem is most acute in rural India, which accounts for over half of India’s population; about 80 percent of available hospital beds are located in the urban centers, leaving only 20 percent for the larger rural population. Both the Indian government and the private sector are striving to bring about rapid growth in the industry to manage the increased demand for high quality service. Construction of several new hospitals as well as upgrades of existing hospitals is planned. Healthcare is provided through primary care facilities, secondary and tertiary care hospitals. While the first two categories are fully managed by the government, tertiary care hospitals are owned and managed either by government or private sector. The growth in medical infrastructure is accompanied by increased demand for medical equipment/devices. The medical equipment segment is growing at an impressive rate of 15 percent. The demand for the medical equipment is expected to reach $5 billion by 2012, reflecting significant growth from the current figure of $2.7 billion. The new specialty and super-specialty hospital facilities depend on the import of highend medical equipment, which accounts for over 65 percent of the entire healthcare market. The demand is primarily for high-tech devices. Most Indian healthcare institutes use foreign medical equipment for the purpose of diagnosis, treatment and surgery. The government has identified healthcare as a priority sector and has taken the PO 00000 Frm 00008 Fmt 4703 Sfmt 4703 following measures to promote this industry: • 100 per cent foreign direct investment (FDI) is permitted for health and medical services under the automatic route. (FDI in sectors/ activities to the extent permitted under automatic route does not require any prior approval either by the Government or Reserve Bank of India (RBI). The investors are only required to notify the Regional Office concerned of RBI within 30 days of receipt of inward remittances and file the required documents with that office within 30 days of issue of shares of foreign investors. • The National Rural Health Mission (NRHM) has allocated US$ 10.15 billion for the up-grading and capacity enhancement of healthcare facilities. • Moreover, in order to meet the revised cost of construction, in March 2010 the Government of India (GOI) allocated an additional US$ 1.2 billion for the construction of six All India Institute of Medical Sciences (AIIMS)like institutes and up- grade of 13 existing Government Medical Colleges. Medical tourism is one of the major external drivers of growth of the Indian healthcare sector. The cost of major surgeries in India remains relatively low. Government and private sector estimates the value of this segment of the industry will reach $1.5 billion by 2012. The healthcare industry is now proactively creating standards for the medical tourism industry with the help of credit rating agencies, insurance companies and others involved in the self regulation of the sector. The National Accreditation Board for Hospitals (NABH) has been set-up to establish and operate accreditation programs for healthcare organizations. Some private hospitals are also applying for accreditation from bodies such as the Joint Commission International (JCI). The growth in this industry makes it very attractive for U.S. companies, both large companies already doing business in the market but also and especially small- and medium- sized enterprises (SMEs), and new-to-market (NTM) companies. Mission Goals The goal of the Medical Trade Mission to India is to (1) familiarize the participants with the current healthcare situation as well as the developments taking place in India (2) introduce participants to government officials in India to learn about various regulatory procedures and policies in the healthcare sector (3) introduce participants to Indian companies for potential partnerships. E:\FR\FM\10NON1.SGM 10NON1 Federal Register / Vol. 76, No. 218 / Thursday, November 10, 2011 / Notices Mission Scenario The first stop on the mission itinerary is Mumbai, the financial capital of India, located in western India. New Delhi and Hyderabad are the second and third stops of the mission and are located in northern and western India. Several corporate hospital chains have their headquarters in these cities. These include Max group and Medicity Medanta in New Delhi, the Apollo group in Hyderabad, Fortis and the Tata Research in Mumbai. In all three cities the delegates will attend Embassy and industry briefings, networking events and take part in business matchmaking appointments with private-sector organizations. As New Delhi is the capital city and home to Central (Federal) Government, the participants will have an opportunity in New Delhi to meet the representatives of the Ministry of Health, Drugs Controller Generals Office, and Department of Pharmaceutical. The U.S. mission Friday, March 2 ................................................... Saturday, March 3 ............................................... Sunday, March 4 ................................................. Monday, March 5 ................................................ Tuesday, March 6 ............................................... Wednesday, March 7 .......................................... jlentini on DSK4TPTVN1PROD with NOTICES Thursday, March 8 .............................................. VerDate Mar<15>2010 16:38 Nov 09, 2011 Jkt 226001 members will learn about policies, procedures and opportunities in the country’s healthcare industry. These three cities are each regional hubs for the medical/healthcare industry. The end-users of the healthcare industry often prefer to be serviced by regional distributors/agents rather than country-wide distributors. Thus, medical equipment importers/ distributors are based in these cities to supply and service the regions surrounding each of the cities. The three cities will serve as good locations for business one-on-one matchmaking meetings and networking. U.S. participants will be counseled before and after the mission by U.S. Export Assistance Center trade specialists, primarily by members of the Global Healthcare Team. Participation in the mission will include the following: • Pre-travel briefings/Webinar on subjects ranging from business practices in India to security; 70115 • Embassy/Consulate briefings on the business climate, political scenario, medical/healthcare industry scenario; • Industry briefings ‘‘Doing business in India—focus sector medical/ healthcare’’; • Pre-scheduled meetings with potential partners, distributors, end users, or local industry contacts in Mumbai, New Delhi and Hyderabad; • Meetings with Indian Government officials in New Delhi; • Tour of hospitals and interaction with senior hospital staff and procurement head (all the three stops); and • Networking receptions in three cities of the trade mission. Proposed Timetable Mission participants will be encouraged to arrive Thursday, March 1, 2012 to allow time to adjust to their new surroundings before the mission program begins on Friday, March 2. Mumbai. Morning: Consulate & Industry briefing by U.S. Department of Commerce at the hotel. Noon/Afternoon: Option I—Trade Mission. One-on-One business matchmaking appointments at the hotel. Lunch—private lunch. Option II—participate/exhibit in Medical Fair 2012 by Messe Dusseldorf. Evening: Networking reception at the hotel. Mumbai/New Delhi. Option I— Morning: One-on-One business matchmaking appointments at the hotel. Late afternoon: Check-out of the hotel & depart for Mumbai airport. Travel to New Delhi. Evening: Arrive New Delhi. Option II—participate/exhibit in Medical Fair 2012 by Messe Dusseldorf. Delegates in Option 2 depart for New Delhi on Sunday, March 4, 2011. New Delhi. Free day for the delegates in Option 1/Travel Day for the Delegates in Option II. New Delhi. Morning: Breakfast briefing by the U.S. Commercial Service at hotel. Meetings with the Government of India Ministries. Lunch: Private lunch. Afternoon: One-on-one matchmaking meeting at the hotel Evening: Networking reception. New Delhi/Hyderabad. Morning: One-on-one matchmaking meeting at the hotel. Lunch on own. Late afternoon: Check-out of the hotel & depart for New Delhi airport. Travel to Hyderabad. Evening: Arrive Hyderabad. Hyderabad. Morning: One-on-One business matchmaking appointments at the hotel. Private lunch. Afternoon: One-on-One business matchmaking appointments at the hotel. Evening: Networking reception. Hyderabad. Hospital chain visit and meeting with senior management. Lunch on own. Evening: Check-out of the hotel. Depart for Hyderabad International airport for onward travel. PO 00000 Frm 00009 Fmt 4703 Sfmt 4703 E:\FR\FM\10NON1.SGM 10NON1 70116 Federal Register / Vol. 76, No. 218 / Thursday, November 10, 2011 / Notices Participation Requirements All parties interested in participating in the India Medical Trade Mission must complete and submit an application for consideration by the Department of Commerce. All applicants will be evaluated on their ability to meet certain conditions and best satisfy the selection criteria as outlined below. A minimum of 15 and a maximum of 20 companies will be selected to participate in the mission from the applicant pool. U.S. companies already doing business in India as well as U.S. companies seeking to enter the Indian market for the first may apply. Fees and Expenses After a company or organization has been selected to participate on the mission, a payment to the Department of Commerce in the form of a participation fee is required. Option 1: The participation fee for the three city (Mumbai, New Delhi and Hyderabad) Trade Mission will be $4537.00 for a small or medium-sized enterprise (SME),* or trade organization, and $5225.00 for large firms. The fee for each additional firm representative (large firm or SME/trade organization) is $500. Option 2: Fee, for participants joining the Trade Mission in two-cities (Delhi and Hyderabad) will be $3,275.00 for SMEs or trade organizations, and $3950.00 for large companies. The fee for each additional firm representative (large firm or SME/trade organization) is $500. Selecting option II * in Mumbai i.e. exhibiting in Medical Fair India * will be approximately $3547.00 for 9 sq.m. shell scheme space + $578.00 as registration fees (this will be billed in Euros). (* Fee for participating in the Medical Fair 2012 is separate and will have to be paid directly to the organizers Messe Dusseldorf.) Expenses for lodging, some meals, incidentals, and travel (except for transportation to and from meetings) will be the responsibility of each mission participant. application and supplemental application materials, including adequate information on the company’s products and/or services (or in the case of a trade association or trade organization, information on the products and/or services of the companies to be represented on the trade mission), primary market objectives, and goals for participation. If the Department of Commerce receives an incomplete application, the Department may reject the application, request additional information, or take the lack of information into account when evaluating the applications. • Each applicant must also certify that the products and services it seeks to export through the mission are either produced in the United States, or, if not, marketed under the name of a U.S. firm and have at least fifty-one percent U.S. content. In the case of a trade association or trade organization, the applicant must certify that, for each company to be represented by the trade association or trade organization, the products and services the represented company seeks to export are either produced in the United States, or, if not, marketed under the name of a U.S. firm and have at least fifty-one percent U.S. content. jlentini on DSK4TPTVN1PROD with NOTICES Conditions for Participation • An applicant must submit a completed and signed mission Selection Criteria for Participation Selection will be based on the following criteria: • Suitability of a company’s (or, the case of a trade association or trade organization, representing companies’) products or services to the mission’s goals. • Company’s (or, in the case of a trade association or trade organization, represented companies’) potential for business in India, including likelihood of exports resulting from the trade mission. • Consistency of the applicant’s goals and objectives with the stated scope of the trade mission. Referrals from political organizations and any documents containing references to partisan political activities (including political contributions) will be removed from an applicant’s submission and not considered during the selection process. * An SME is defined as a firm with 500 or fewer employees or that otherwise qualifies as a small business under SBA regulations (see https:// www.sba.gov/category/navigation-structure/ contracting/contracting-officials/size-standards). Parent companies, affiliates, and subsidiaries will be considered when determining business size. The dual pricing schedule reflects the Commercial Service’s user fee schedule that became effective May 1, 2008 (for additional information see https://www.export.gov/newsletter/march2008/ initiatives.html). Timeframe for Recruitment and Applications Mission recruitment will be conducted in an open and public manner, including publication in the Federal Register (https:// www.gpoaccess.gov/fr), posting on ITA’s trade mission calendar—www.trade.gov/ trade-missions—and other Internet Web sites, press releases to general and trade VerDate Mar<15>2010 16:38 Nov 09, 2011 Jkt 226001 PO 00000 Frm 00010 Fmt 4703 Sfmt 4703 media, direct mail, broadcast fax, notices by industry trade associations and other multiplier groups, and publicity at industry meetings, symposia, conferences, and trade shows. Recruitment for the mission will begin immediately and conclude no later than December 22, 2011. The U.S. Department of Commerce will review applications and make selection decisions on a rolling basis. We will inform all applicants of selection decisions as soon as possible after the applications are reviewed. Applications received after the December 22 deadline will be considered only if space and scheduling constraints permit. Contacts U.S. Commercial Service Ms. September Secrist, Healthcare Team: International Trade Specialist, U.S. Commercial Service, U.S. Department of Commerce, 2001 6th Avenue, Suite 2610, Seattle, WA 98121, Phone: (206) 553–5615x229, Fax: (206) 553–7253. U.S. Commercial Service in India Ms. Ruma Chatterjee, U.S. Commercial Service Mumbai, Ph: 91–22–2265 2511, Fax: 91–22–22652850, Ruma.Chatterjee@trade.gov. Mr. Sandeep Maini, U.S. Commercial Service New Delhi, Ph: 91–11– 23472222, Fax: 91–11–2331 5172, Sandeep.Maini@trade.gov. Elnora Moye, Trade Program Assistant. [FR Doc. 2011–28590 Filed 11–9–11; 8:45 am] BILLING CODE 3510–FP–P DEPARTMENT OF COMMERCE National Oceanic and Atmospheric Administration (NOAA) National Climate Assessment and Development Advisory Committee (NCADAC) Office of Oceanic and Atmospheric Research (OAR), National Oceanic and Atmospheric Administration (NOAA), Department of Commerce (DOC). ACTION: Notice of time changes for public meeting and public comment period. AGENCY: The National Climate Assessment and Development Advisory Committee (NCADAC) was established by the Secretary of Commerce under the authority of the Global Change Research Act of 1990 to synthesize and summarize the science and information SUMMARY: E:\FR\FM\10NON1.SGM 10NON1

Agencies

[Federal Register Volume 76, Number 218 (Thursday, November 10, 2011)]
[Notices]
[Pages 70113-70116]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-28590]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration


Executive-Led Medical Trade Mission to India Mumbai, New Delhi 
and Hyderabad March 2-8, 2012

AGENCY: International Trade Administration, Commerce.

ACTION: Notice.

-----------------------------------------------------------------------

Mission Description

    The United States Department of Commerce, International Trade 
Administration, U.S. and Foreign Commercial Service (CS) is organizing 
an Executive-Led Medical Trade Mission to India from March 2-8, 2012.
    The Medical Trade Mission to India is intended to include 
representatives from a variety of U.S. medical/healthcare industry 
manufacturers (equipment/devices, laboratory equipments, emergency 
equipment, diagnostic, physiotherapy and orthopedic, healthcare 
information technology, and other allied sectors), service providers, 
and associations and trade organizations. The mission will introduce 
the participants to the government bodies, end-users and prospective 
partners whose needs and capabilities are best suited to each U.S. 
participant's strengths. Participating in an official U.S. industry 
delegation, rather than traveling to India on their own, will enhance 
the participants'

[[Page 70114]]

ability to secure meetings in India. The delegates will meet with 
government officials to obtain first-hand information about the 
regulations, policies and procedures in the healthcare industry. It 
will be an opportunity for participants to visit healthcare facilities 
to get acquainted with the functioning of hospitals in India and the 
varied standards. Market forces, such as medical tourism, insurance and 
corporate sector have accelerated the demand for quality in healthcare 
services. As a result, there is a growing demand from consumers for 
better healthcare as the lack of quality assurance mechanisms limits 
their access to appropriate health services. The Healthcare industry is 
now proactively creating standards for the medical tourism industry 
with the help of credit rating agencies, insurance companies and others 
involved in the self regulation of the sector. The National 
Accreditation Board for Hospitals (NABH) has been set-up to establish 
and operate accreditation programs for healthcare organizations. Some 
private hospitals are also applying for accreditation from bodies such 
as the Joint Commission International (JCI). The mission will include 
appointments and briefings in Mumbai, New Delhi and Hyderabad, India's 
major healthcare industry hubs. Trade mission participants will have 
the opportunity to interact extensively with Embassy/Consulate 
Officials and Commercial Service (CS) India healthcare specialists, to 
discuss industry developments, opportunities, and sales strategies.
    There is an option in the mission to participate in Medical Fair 
India. The Medical Fair India is the 18th International Exhibition and 
Conference on Diagnostic, Medical Technology, Rehabilitation, Medical 
Equipment and Components. MEDICAL FAIR INDIA offers a new platform for 
technology and service solutions for use in the medical engineering 
industry--from new materials, components, intermediate products, 
packaging and services all the way over to more complex micro system 
technology and nanotechnology. For more information on Medical Fair 
India, please visit https://www.medicalfair-india.com/. For the last 
three years the U.S. Department of Commerce has certified the Medical 
Fair India.

Commercial Setting

    The Indian healthcare industry is experiencing a rapid 
transformation and emerging to be a promising market for U.S. suppliers 
of high end products seeking partnership opportunities. The Indian 
healthcare industry is estimated at $50 billion industry in India and 
is expected to reach over $75 billion by 2012. There is a growing 
demand for quality healthcare service. The Indian population of 1 
billion people is growing at a rate of 1.6 percent per year. The growth 
in affluence in India, which now has over 400 million middle-income 
consumers, is creating demand for a higher standard of healthcare. The 
type of healthcare serviced required have changed due to the change in 
the demographic profile of India and the rise of lifestyle-related 
diseases such as diabetes, cardiovascular diseases, and diseases of the 
central nervous system. The number of individuals covered by health 
plans is estimated at 20 million presently, leaving a large portion of 
the Indian population uninsured. The potential market for healthcare 
services, including healthcare information and management systems, is 
expected to grow at a faster pace as hospitals strive to improve 
operational efficiencies in managing patient records and other key 
systems.
    Currently, the medical infrastructure in India is far from adequate 
with demand for hospitals and beds far surpassing availability. The 
problem is most acute in rural India, which accounts for over half of 
India's population; about 80 percent of available hospital beds are 
located in the urban centers, leaving only 20 percent for the larger 
rural population. Both the Indian government and the private sector are 
striving to bring about rapid growth in the industry to manage the 
increased demand for high quality service. Construction of several new 
hospitals as well as upgrades of existing hospitals is planned. 
Healthcare is provided through primary care facilities, secondary and 
tertiary care hospitals. While the first two categories are fully 
managed by the government, tertiary care hospitals are owned and 
managed either by government or private sector.
    The growth in medical infrastructure is accompanied by increased 
demand for medical equipment/devices. The medical equipment segment is 
growing at an impressive rate of 15 percent. The demand for the medical 
equipment is expected to reach $5 billion by 2012, reflecting 
significant growth from the current figure of $2.7 billion. The new 
specialty and super-specialty hospital facilities depend on the import 
of high-end medical equipment, which accounts for over 65 percent of 
the entire healthcare market. The demand is primarily for high-tech 
devices. Most Indian healthcare institutes use foreign medical 
equipment for the purpose of diagnosis, treatment and surgery. The 
government has identified healthcare as a priority sector and has taken 
the following measures to promote this industry:
     100 per cent foreign direct investment (FDI) is permitted 
for health and medical services under the automatic route. (FDI in 
sectors/activities to the extent permitted under automatic route does 
not require any prior approval either by the Government or Reserve Bank 
of India (RBI). The investors are only required to notify the Regional 
Office concerned of RBI within 30 days of receipt of inward remittances 
and file the required documents with that office within 30 days of 
issue of shares of foreign investors.
     The National Rural Health Mission (NRHM) has allocated US$ 
10.15 billion for the up-grading and capacity enhancement of healthcare 
facilities.
     Moreover, in order to meet the revised cost of 
construction, in March 2010 the Government of India (GOI) allocated an 
additional US$ 1.2 billion for the construction of six All India 
Institute of Medical Sciences (AIIMS)-like institutes and up- grade of 
13 existing Government Medical Colleges.
    Medical tourism is one of the major external drivers of growth of 
the Indian healthcare sector. The cost of major surgeries in India 
remains relatively low. Government and private sector estimates the 
value of this segment of the industry will reach $1.5 billion by 2012. 
The healthcare industry is now proactively creating standards for the 
medical tourism industry with the help of credit rating agencies, 
insurance companies and others involved in the self regulation of the 
sector. The National Accreditation Board for Hospitals (NABH) has been 
set-up to establish and operate accreditation programs for healthcare 
organizations. Some private hospitals are also applying for 
accreditation from bodies such as the Joint Commission International 
(JCI).
    The growth in this industry makes it very attractive for U.S. 
companies, both large companies already doing business in the market 
but also and especially small- and medium- sized enterprises (SMEs), 
and new-to-market (NTM) companies.

Mission Goals

    The goal of the Medical Trade Mission to India is to (1) 
familiarize the participants with the current healthcare situation as 
well as the developments taking place in India (2) introduce 
participants to government officials in India to learn about various 
regulatory procedures and policies in the healthcare sector (3) 
introduce participants to Indian companies for potential partnerships.

[[Page 70115]]

Mission Scenario

    The first stop on the mission itinerary is Mumbai, the financial 
capital of India, located in western India. New Delhi and Hyderabad are 
the second and third stops of the mission and are located in northern 
and western India. Several corporate hospital chains have their 
headquarters in these cities. These include Max group and Medicity 
Medanta in New Delhi, the Apollo group in Hyderabad, Fortis and the 
Tata Research in Mumbai.
    In all three cities the delegates will attend Embassy and industry 
briefings, networking events and take part in business matchmaking 
appointments with private-sector organizations. As New Delhi is the 
capital city and home to Central (Federal) Government, the participants 
will have an opportunity in New Delhi to meet the representatives of 
the Ministry of Health, Drugs Controller Generals Office, and 
Department of Pharmaceutical. The U.S. mission members will learn about 
policies, procedures and opportunities in the country's healthcare 
industry.
    These three cities are each regional hubs for the medical/
healthcare industry. The end-users of the healthcare industry often 
prefer to be serviced by regional distributors/agents rather than 
country-wide distributors. Thus, medical equipment importers/
distributors are based in these cities to supply and service the 
regions surrounding each of the cities. The three cities will serve as 
good locations for business one-on-one matchmaking meetings and 
networking.
    U.S. participants will be counseled before and after the mission by 
U.S. Export Assistance Center trade specialists, primarily by members 
of the Global Healthcare Team. Participation in the mission will 
include the following:
     Pre-travel briefings/Webinar on subjects ranging from 
business practices in India to security;
     Embassy/Consulate briefings on the business climate, 
political scenario, medical/healthcare industry scenario;
     Industry briefings ``Doing business in India--focus sector 
medical/healthcare'';
     Pre-scheduled meetings with potential partners, 
distributors, end users, or local industry contacts in Mumbai, New 
Delhi and Hyderabad;
     Meetings with Indian Government officials in New Delhi;
     Tour of hospitals and interaction with senior hospital 
staff and procurement head (all the three stops); and
     Networking receptions in three cities of the trade 
mission.

Proposed Timetable

    Mission participants will be encouraged to arrive Thursday, March 
1, 2012 to allow time to adjust to their new surroundings before the 
mission program begins on Friday, March 2.

------------------------------------------------------------------------
 
------------------------------------------------------------------------
Friday, March 2...................  Mumbai.
                                    Morning: Consulate & Industry
                                     briefing by U.S. Department of
                                     Commerce at the hotel.
                                    Noon/Afternoon:
                                    Option I--Trade Mission.
                                    One-on-One business matchmaking
                                     appointments at the hotel.
                                    Lunch--private lunch.
                                    Option II--participate/exhibit in
                                     Medical Fair 2012 by Messe
                                     Dusseldorf.
                                    Evening: Networking reception at the
                                     hotel.
Saturday, March 3.................  Mumbai/New Delhi.
                                    Option I--
                                    Morning: One-on-One business
                                     matchmaking appointments at the
                                     hotel.
                                    Late afternoon: Check-out of the
                                     hotel & depart for Mumbai airport.
                                    Travel to New Delhi.
                                    Evening: Arrive New Delhi.
                                    Option II--participate/exhibit in
                                     Medical Fair 2012 by Messe
                                     Dusseldorf. Delegates in Option 2
                                     depart for New Delhi on Sunday,
                                     March 4, 2011.
Sunday, March 4...................  New Delhi.
                                    Free day for the delegates in Option
                                     1/Travel Day for the Delegates in
                                     Option II.
Monday, March 5...................  New Delhi.
                                    Morning: Breakfast briefing by the
                                     U.S. Commercial Service at hotel.
                                    Meetings with the Government of
                                     India Ministries.
                                    Lunch: Private lunch.
                                    Afternoon: One-on-one matchmaking
                                     meeting at the hotel
                                    Evening: Networking reception.
Tuesday, March 6..................  New Delhi/Hyderabad.
                                    Morning: One-on-one matchmaking
                                     meeting at the hotel.
                                    Lunch on own.
                                    Late afternoon: Check-out of the
                                     hotel & depart for New Delhi
                                     airport.
                                    Travel to Hyderabad.
                                    Evening: Arrive Hyderabad.
Wednesday, March 7................  Hyderabad.
                                    Morning: One-on-One business
                                     matchmaking appointments at the
                                     hotel.
                                    Private lunch.
                                    Afternoon: One-on-One business
                                     matchmaking appointments at the
                                     hotel.
                                    Evening: Networking reception.
Thursday, March 8.................  Hyderabad.
                                    Hospital chain visit and meeting
                                     with senior management.
                                    Lunch on own.
                                    Evening: Check-out of the hotel.
                                    Depart for Hyderabad International
                                     airport for onward travel.
------------------------------------------------------------------------


[[Page 70116]]

Participation Requirements

    All parties interested in participating in the India Medical Trade 
Mission must complete and submit an application for consideration by 
the Department of Commerce. All applicants will be evaluated on their 
ability to meet certain conditions and best satisfy the selection 
criteria as outlined below. A minimum of 15 and a maximum of 20 
companies will be selected to participate in the mission from the 
applicant pool. U.S. companies already doing business in India as well 
as U.S. companies seeking to enter the Indian market for the first may 
apply.

Fees and Expenses

    After a company or organization has been selected to participate on 
the mission, a payment to the Department of Commerce in the form of a 
participation fee is required.
    Option 1: The participation fee for the three city (Mumbai, New 
Delhi and Hyderabad) Trade Mission will be $4537.00 for a small or 
medium-sized enterprise (SME),* or trade organization, and $5225.00 for 
large firms. The fee for each additional firm representative (large 
firm or SME/trade organization) is $500.
    Option 2: Fee, for participants joining the Trade Mission in two-
cities (Delhi and Hyderabad) will be $3,275.00 for SMEs or trade 
organizations, and $3950.00 for large companies. The fee for each 
additional firm representative (large firm or SME/trade organization) 
is $500. Selecting option II * in Mumbai i.e. exhibiting in Medical 
Fair India * will be approximately $3547.00 for 9 sq.m. shell scheme 
space + $578.00 as registration fees (this will be billed in Euros).
    (* Fee for participating in the Medical Fair 2012 is separate and 
will have to be paid directly to the organizers Messe Dusseldorf.)
---------------------------------------------------------------------------

    * An SME is defined as a firm with 500 or fewer employees or 
that otherwise qualifies as a small business under SBA regulations 
(see https://www.sba.gov/category/navigation-structure/contracting/contracting-officials/size-standards). Parent companies, affiliates, 
and subsidiaries will be considered when determining business size. 
The dual pricing schedule reflects the Commercial Service's user fee 
schedule that became effective May 1, 2008 (for additional 
information see https://www.export.gov/newsletter/march2008/initiatives.html).
---------------------------------------------------------------------------

    Expenses for lodging, some meals, incidentals, and travel (except 
for transportation to and from meetings) will be the responsibility of 
each mission participant.

Conditions for Participation

     An applicant must submit a completed and signed mission 
application and supplemental application materials, including adequate 
information on the company's products and/or services (or in the case 
of a trade association or trade organization, information on the 
products and/or services of the companies to be represented on the 
trade mission), primary market objectives, and goals for participation. 
If the Department of Commerce receives an incomplete application, the 
Department may reject the application, request additional information, 
or take the lack of information into account when evaluating the 
applications.
     Each applicant must also certify that the products and 
services it seeks to export through the mission are either produced in 
the United States, or, if not, marketed under the name of a U.S. firm 
and have at least fifty-one percent U.S. content. In the case of a 
trade association or trade organization, the applicant must certify 
that, for each company to be represented by the trade association or 
trade organization, the products and services the represented company 
seeks to export are either produced in the United States, or, if not, 
marketed under the name of a U.S. firm and have at least fifty-one 
percent U.S. content.

Selection Criteria for Participation

    Selection will be based on the following criteria:
     Suitability of a company's (or, the case of a trade 
association or trade organization, representing companies') products or 
services to the mission's goals.
     Company's (or, in the case of a trade association or trade 
organization, represented companies') potential for business in India, 
including likelihood of exports resulting from the trade mission.
     Consistency of the applicant's goals and objectives with 
the stated scope of the trade mission.
    Referrals from political organizations and any documents containing 
references to partisan political activities (including political 
contributions) will be removed from an applicant's submission and not 
considered during the selection process.

Timeframe for Recruitment and Applications

    Mission recruitment will be conducted in an open and public manner, 
including publication in the Federal Register (https://www.gpoaccess.gov/fr), posting on ITA's trade mission calendar--
www.trade.gov/trade-missions--and other Internet Web sites, press 
releases to general and trade media, direct mail, broadcast fax, 
notices by industry trade associations and other multiplier groups, and 
publicity at industry meetings, symposia, conferences, and trade shows.
    Recruitment for the mission will begin immediately and conclude no 
later than December 22, 2011. The U.S. Department of Commerce will 
review applications and make selection decisions on a rolling basis. We 
will inform all applicants of selection decisions as soon as possible 
after the applications are reviewed. Applications received after the 
December 22 deadline will be considered only if space and scheduling 
constraints permit.

Contacts

U.S. Commercial Service

Ms. September Secrist, Healthcare Team: International Trade Specialist, 
U.S. Commercial Service, U.S. Department of Commerce, 2001 6th Avenue, 
Suite 2610, Seattle, WA 98121, Phone: (206) 553-5615x229, Fax: (206) 
553-7253.

U.S. Commercial Service in India

Ms. Ruma Chatterjee, U.S. Commercial Service Mumbai, Ph: 91-22-2265 
2511, Fax: 91-22-22652850, Ruma.Chatterjee@trade.gov.
Mr. Sandeep Maini, U.S. Commercial Service New Delhi, Ph: 91-11-
23472222, Fax: 91-11-2331 5172, Sandeep.Maini@trade.gov.

Elnora Moye,
Trade Program Assistant.
[FR Doc. 2011-28590 Filed 11-9-11; 8:45 am]
BILLING CODE 3510-FP-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.